Literature DB >> 27396943

Results of less radical fertility-sparing procedures with omitted parametrectomy for cervical cancer: 5years of experience.

Jiri Slama1, Andrej Cerny2, Ladislav Dusek3, Daniela Fischerova2, Michal Zikan2, Roman Kocian2, Anna Germanova2, David Cibula2.   

Abstract

OBJECTIVE: The aim of our study was to describe oncological and obstetrical outcomes in patients who underwent less radical fertility-sparing surgical (FSS) procedures with omitted parametrectomy for cervical cancer.
METHODS: Included were women with cervical cancer stages IA2-IB2 who were under the age of 40 and desired future pregnancy. Patients underwent pelvic lymphadenectomy and sentinel lymph node biopsy. Node-negative cases underwent subsequent cervical surgery and were further analyzed. Neoadjuvant chemotherapy (NAC) was administered in patients with tumors >2cm and/or involving >2/3 of cervical stroma. Simple vaginal trachelectomy or needle conization were performed according to tumor extent and topography. The follow-up period started once free surgical margins were reached.
RESULTS: Out of 44 women enrolled, 32 women (IA2=7, IB1=23, IB2=2) successfully completed FSS. NAC was administered in 9 (28.1%) cases. A simple trachelectomy was performed in 11 patients and needle conization in 21 patients. During the follow-up, 6 out of 32 women became pregnant. Of these, 1 miscarried and 5 successfully delivered. Disease recurred in 6 patients; 5 recurrences were central and 1 recurrence presented as an ovarian mass. Invasive cervical carcinoma, high-grade squamous intraepithelial (HSIL), and low-grade squamous intraepithelial (LSIL) lesions were detected in 4, 1 and 1 patients, respectively. Three of them received NAC. All events were detected within 16months after surgery.
CONCLUSIONS: Nearly 27% of patients cannot complete FSS due to node positivity, progression during NAC, or involved margins. The total recurrence rate reached 18.8%, with the majority of invasive recurrences detected in patients after NAC followed by FSS. These patients represent cases at a higher risk of recurrence even if adequate free margins are reached by surgery. Nearly half of the cohort did not consider pregnancy in the near future because of personal reasons.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Conization; Fertility-sparing surgery; Trachelectomy

Mesh:

Year:  2016        PMID: 27396943     DOI: 10.1016/j.ygyno.2016.07.008

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  Staging, recurrence and follow-up of uterine cervical cancer using MRI: Updated Guidelines of the European Society of Urogenital Radiology after revised FIGO staging 2018.

Authors:  Lucia Manganaro; Yulia Lakhman; Nishat Bharwani; Benedetta Gui; Silvia Gigli; Valeria Vinci; Stefania Rizzo; Aki Kido; Teresa Margarida Cunha; Evis Sala; Andrea Rockall; Rosemarie Forstner; Stephanie Nougaret
Journal:  Eur Radiol       Date:  2021-04-14       Impact factor: 5.315

2.  Predictive Factors for Residual Disease After Conization in Cervical Cancer.

Authors:  Glauco Baiocchi; Thiago Pereira Diniz; Graziele Bovolim; Bruna Tirapelli Gonçalves; Lillian Yuri Kumagai; Henrique Mantoan; Carlos Chaves Faloppa; Andrea Paiva Gadelha Guimaraes; Alexandre Andre Balieiro Anastacio da Costa; Levon Badiglian-Filho; Louise De Brot
Journal:  Ann Surg Oncol       Date:  2021-02-10       Impact factor: 5.344

Review 3.  Fertility-Sparing Treatment for Early-Stage Cervical Cancer ≥ 2 cm: A Problem with a Thousand Nuances-A Systematic Review of Oncological Outcomes.

Authors:  Carlo Ronsini; Maria Cristina Solazzo; Nicolò Bizzarri; Domenico Ambrosio; Marco La Verde; Marco Torella; Raffaela Maria Carotenuto; Luigi Cobellis; Nicola Colacurci; Pasquale De Franciscis
Journal:  Ann Surg Oncol       Date:  2022-09-05       Impact factor: 4.339

4.  Practical recommendations for fertility preservation in women by the FertiPROTEKT network. Part I: Indications for fertility preservation.

Authors:  A N Schüring; T Fehm; K Behringer; M Goeckenjan; P Wimberger; M Henes; J Henes; M F Fey; M von Wolff
Journal:  Arch Gynecol Obstet       Date:  2017-11-24       Impact factor: 2.344

Review 5.  Neoadjuvant Chemotherapy Prior Fertility-Sparing Surgery in Women with FIGO 2018 Stage IB2 Cervical Cancer: A Systematic Review.

Authors:  Alessandro Buda; Martina Borghese; Andrea Puppo; Stefania Perotto; Antonia Novelli; Chiara Borghi; Elena Olearo; Elisa Tripodi; Alessandra Surace; Enrica Bar; Giovanni Scambia; Francesco Fanfani
Journal:  Cancers (Basel)       Date:  2022-02-04       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.